GAMBACORTI PASSERINI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 1024
EU - Europa 277
AS - Asia 94
AF - Africa 12
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1418
Nazione #
US - Stati Uniti d'America 1000
IT - Italia 75
DE - Germania 65
CZ - Repubblica Ceca 32
CN - Cina 31
RU - Federazione Russa 27
GB - Regno Unito 22
CA - Canada 19
JP - Giappone 15
UA - Ucraina 11
ZA - Sudafrica 10
IE - Irlanda 9
VN - Vietnam 9
CL - Cile 8
FR - Francia 8
HK - Hong Kong 7
IN - India 7
NL - Olanda 7
ES - Italia 5
MX - Messico 5
SG - Singapore 5
KR - Corea 4
LB - Libano 4
TR - Turchia 4
IL - Israele 3
SE - Svezia 3
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
ID - Indonesia 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
EU - Europa 1
FI - Finlandia 1
MK - Macedonia 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
Totale 1418
Città #
Santa Cruz 158
Fairfield 108
Buffalo 55
Woodbridge 48
Seattle 47
Houston 46
Frankfurt am Main 42
Cambridge 40
Ashburn 38
Wilmington 31
Ann Arbor 22
Milan 16
Palo Alto 14
Beijing 12
Chicago 11
Las Vegas 11
Mountain View 11
Dublin 9
Andover 8
Clearwater 8
Muizenberg 8
Toronto 8
Wuhan 8
Dong Ket 7
New York 7
Ottawa 7
San Francisco 7
Henderson 6
Phoenix 6
San Diego 6
Torino 6
Heerhugowaard 5
Padova 5
Saint Petersburg 5
San Jose 5
Central 4
Fleming Island 4
Lake Forest 4
Parsippany 4
Riva 4
Auburn 3
Büdelsdorf 3
Frankfurt Am Main 3
Hangzhou 3
Jacksonville 3
London 3
Los Angeles 3
Provo 3
Redmond 3
Rome 3
Somerville 3
Turin 3
University Park 3
Ahi'ezer 2
Boardman 2
Bologna 2
Boston 2
Charlotte 2
Collegeville 2
Columbus 2
Dallas 2
Des Moines 2
Girona 2
Jönköping 2
Lombard 2
Mexico 2
Ningbo 2
Norwalk 2
Pavia 2
Piemonte 2
Portland 2
Providence 2
Rockville 2
Santiago 2
Sassari 2
Seoul 2
Silverton 2
Singapore 2
Tampa 2
Verona 2
Yellow Springs 2
Amsterdam 1
Ankaran 1
Arnsberg 1
Baltimore 1
Bangalore 1
Bar Harbor 1
Beirut 1
Belmont 1
Berbenno di Valtellina 1
Berlin 1
Birmingham 1
Brookfield 1
Cairo 1
Cardano al Campo 1
Caserta 1
Chengdu 1
Cheyenne 1
Council Bluffs 1
Crugers 1
Totale 965
Nome #
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes, file e39773b4-fcf0-35a3-e053-3a05fe0aac26 224
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways, file e39773b6-139c-35a3-e053-3a05fe0aac26 139
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells, file e39773b4-fcf3-35a3-e053-3a05fe0aac26 126
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer, file e39773b7-8f53-35a3-e053-3a05fe0aac26 119
Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling, file e39773b5-3a31-35a3-e053-3a05fe0aac26 114
An Imatinib–non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization, file e39773b6-422d-35a3-e053-3a05fe0aac26 100
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes, file e39773b3-cf4a-35a3-e053-3a05fe0aac26 90
C-MYC generates repair errors via increased transcription of alternative-NHEJ factors, LIG3 and PARP1, in tyrosine kinase-activated leukemias, file e39773b7-9374-35a3-e053-3a05fe0aac26 66
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922, file e39773b7-9373-35a3-e053-3a05fe0aac26 46
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub, file e39773b7-9cb0-35a3-e053-3a05fe0aac26 46
β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: Implications for a double-targeted therapy, file e39773b7-8f55-35a3-e053-3a05fe0aac26 44
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea, file e39773b7-9caf-35a3-e053-3a05fe0aac26 44
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias, file e39773b7-9e5c-35a3-e053-3a05fe0aac26 44
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes, file e39773b7-9e90-35a3-e053-3a05fe0aac26 43
Treatment patterns in patients with chronic-phase chronic myeloid leukaemia in routine clinical practice: The simplicity Italian population, file e39773b7-8643-35a3-e053-3a05fe0aac26 42
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib, file e39773b7-9375-35a3-e053-3a05fe0aac26 41
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients, file e39773b7-98a0-35a3-e053-3a05fe0aac26 40
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: Expert panel review, file e39773b7-9cb1-35a3-e053-3a05fe0aac26 38
Erratum: Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design (Journal of Medicinal Chemistry (2017) 60:22 (9205-9221) DOI: 10.1021/acs.jmedchem.7b01039), file e39773b7-9325-35a3-e053-3a05fe0aac26 37
The novel PIM1 inhibitor NMS-P645 reverses PIM1-Dependent effects on TMPRSS2/ERG positive Prostate cancer cells and shows anti-proliferative activity in combination with PI3K inhibition, file e39773b7-a222-35a3-e053-3a05fe0aac26 33
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma, file e39773b8-3fbd-35a3-e053-3a05fe0aac26 15
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene, file e39773b2-9e94-35a3-e053-3a05fe0aac26 2
Totale 1493
Categoria #
all - tutte 2489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2489


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20186 0000 00 11 0103
2018/201983 0031 50 05 11122521
2019/2020147 15789 1112 1514 1919117
2020/2021271 12171311 1113 2420 36425418
2021/2022587 33262831 4631 3640 503417656
2022/2023395 405615471 2629 190 0000
Totale 1493